Citation Impact
Citing Papers
Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin
2010
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES
2002
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
Transvascular drug delivery in solid tumors
1998
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel
2003
Nanoparticles in Medicine: Therapeutic Applications and Developments
2007 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The status of gene therapy for brain tumors
2007
Newcastle Disease Virus: A Promising Vector for Viral Therapy, Immune Therapy, and Gene Therapy of Cancer
2009
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions
2003
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation
2011
Antithrombotic Therapy for VTE Disease
2016 Standout
The Utility of Focused Assessment With Sonography for Trauma as a Triage Tool in Multiple-Casualty Incidents During the Second Lebanon War
2007
Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
2009
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel
2000
Convolutional neural networks: an overview and application in radiology
2018 Standout
Anthrazykline in der Krebstherapie
1997 Standout
Point-of-Care Ultrasonography
2011 Standout
Rate of biodistribution of STEALTH® liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity
2002
Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma
2010
Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials
2004
Oncolytic viruses: a new class of immunotherapy drugs
2015
Liposome: classification, preparation, and applications
2013 Standout
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Key issues in non-viral gene delivery1PII of original article: S0169-409X(98)00048-9. The article was originally published in Advanced Drug Delivery Reviews 34 (1998) 3–19.1
2001
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
2020
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma
2011
Biodegradable polymeric nanoparticles based drug delivery systems
2009 Standout
Recent advances in liposomal drug-delivery systems
1995
Biodegradable polymeric nanoparticles as drug delivery devices
2001 Standout
Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
2011
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy
2011
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Malignant Gliomas in Adults
2008 Standout
Cancer Imaging With Fluorine-18–Labeled Choline Derivatives
2007
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Development of liposomal anthracyclines: from basics to clinical applications1This paper is based on a lecture presented at the 8th International Symposium on recent Advances in Drug Delivery Systems (Salt Lake City, UT, USA, 1997).1
1998
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Triad of Acute Infusion‐Related Reactions Associated with Liposomal Amphotericin B: Analysis of Clinical and Epidemiological Characteristics
2003
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
2008
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
2018
The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
2009
Liposomal drug delivery
1996
Liposomes as nanomedical devices
2015 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Polyethylene Glycol-Liposomal Doxorubicin
1997
Systemic Causes of Heel Pain
2010
Nanomaterial standards for efficacy and toxicity assessment
2009
Amphiphilic poly(l-amino acids) — New materials for drug delivery
2012
Nanoparticle and targeted systems for cancer therapy
2004 Standout
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
2011
Paclitaxel and its formulations
2002 Standout
Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism
2009
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Delivering nanomedicine to solid tumors
2010 Standout
Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes
2000
Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles
2007
Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
2009
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Accumulation of Liposomal Lipid and Encapsulated Doxorubicin in Murine Lewis Lung Carcinoma: The Lack of Beneficial Effects by Coating Liposomes with Poly(ethylene glycol)
1997
The Role of Complement Activation in Hypersensitivity to Pegylated Liposomal Doxorubicin (Doxil®)
2000
Clinical Pharmacology of Liposomal Anthracyclines: Focus on Pegylated Liposomal Doxorubicin
2008
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
2005 Standout
Differentially Regulated Interferon Response Determines the Outcome of Newcastle Disease Virus Infection in Normal and Tumor Cell Lines
2006
Nonviral Vectors for Gene Delivery
2008 Standout
Properties of biochar
2018 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Shrink-Wrap Vesicles
2005 StandoutNobel
From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy
2003
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Expression of RIG-I, IRF3, IFN-β and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus
2009
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Controlling liposome blood clearance by surface-grafted polymers
1998
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system.
1998
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
1995
Nanoparticle PEGylation for Imaging and Therapy
2011 Standout
Oncolytic Newcastle Disease Virus for Cancer Therapy: Old Challenges and New Directions
2012
Type I Interferon-Sensitive Recombinant Newcastle Disease Virus for Oncolytic Virotherapy
2010
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Key issues in non-viral gene delivery
1998
Rational design of amphiphile-based drug carriers and sterically stabilized carriers
1995
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
An Updated Definition of Stroke for the 21st Century
2013 Standout
‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
2000 Standout
Size-Dependent Bacterial Growth Inhibition and Mechanism of Antibacterial Activity of Zinc Oxide Nanoparticles
2011 Standout
Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and Efficacy
2006
The Will Rogers Phenomenon in Urological Oncology
2007
Sterically stabilized liposome therapeutics
1995
Works of Eugene Libson being referenced
CT pulmonary angiography for the detection of pulmonary embolism: interobserver agreement between on-call radiology residents and specialists (CTPA interobserver agreement)
2006
Doxil-induced regression of pleuro-pulmonary metastases in a patient with malignant meningioma
2003
Phase I/II Trial of Intravenous NDV-HUJ Oncolytic Virus in Recurrent Glioblastoma Multiforme
2005
Clinical Studies of Liposome-Encapsulated Doxorubicin
1994
Facing the New Threats of Terrorism: Radiologists' Perspectives Based on Experience in Israel
2005
Algorithm Optimization for Multitined Radiofrequency Ablation: Comparative Study in ex Vivo and in Vivo Bovine Liver
2010
Computed Tomography Screening for Lung Cancer: Applicability of an International Protocol in a Single-Institution Environment
2006
Contribution of 11 C-Choline Positron Emission Tomography/Computerized Tomography to Preoperative Staging of Advanced Transitional Cell Carcinoma
2006
Metastatic tumours of bones of the hand and foot
1987